[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650524":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":40,"responsibleParty":53,"collaborators":54,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":24,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":24,"enrollmentInfo":67,"targetDuration":24,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":78,"whyStopped":24,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Seoul National University Dental Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A","EXPERIMENTAL","KH001",[13],"Drug: KH001",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B","Saline",[18],"Drug: Placebo",[20,25],{"type":21,"name":11,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Topical applications of KH001",[9],null,{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Placebo","Topical applications of saline",[15],[30],{"name":31,"affiliation":5,"role":32},"Sun-Young Kim","PRINCIPAL_INVESTIGATOR",[34,38],{"name":31,"role":35,"phone":36,"phoneExt":24,"email":37},"CONTACT","+82-2-502-6700","denkim@snu.ac.kr",{"name":39,"role":35,"phone":24,"phoneExt":24,"email":24},"Keumhee choi",[41],{"facility":5,"status":24,"city":42,"state":24,"zip":24,"country":43,"countryCode":24,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Seoul","South Korea",{"type":45,"coordinates":46},"Point",[47,48],126.9784,37.566,{"lat":48,"lon":47},[51],{"name":52,"role":35,"phone":36,"phoneExt":24,"email":37},"Sun-Young kim",{"type":32,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},[55],{"name":56,"class":57},"HysensBio Co., Ltd","INDUSTRY","100650524","phase-2-a-clinical-study-of-kh001-for-pulp-preservation-and-safety-in-deep-dentin-caries-100650524",false,"NCT07751016","A Clinical Study of KH001 for Pulp Preservation and Safety in Deep Dentin Caries","A Randomized, Single-center, Double-blinded, Placebo-controlled, Investigator-initiated Trial to Evaluate the Efficacy and Safety of KH001 in Patients With Deep Dentinal Caries","Inclusion Criteria:\n\n* Is ≥ 19 years old by the time of the screening visit.\n* Has signed written informed consent in the study.\n* Subjects who can comply with oral hygiene during the study period.\n\nExclusion Criteria:\n\n* Is allergic to the active ingredient or other ingredients used in the investigational product.\n* Have participated in another clinical study within 30 days from screening visit and have a history of administration of investigational product.\n* Is judged by the investigator as ineligible for participation for other reasons.","ALL","19 Years",{"count":68,"type":69},36,"ESTIMATED","INTERVENTIONAL",[72],"PHASE2","The Purpose of this Study is to Evaluate Pulp Preservation and Safety of KH001 in the Administration of Deep Dentin Caries.",[75],"Dental Caries",[77],"caries","NOT_YET_RECRUITING","2026-08-03",{"date":81,"type":82},"2026-08-06","ACTUAL",{"date":84,"type":69},"2026-09-30",{"date":86,"type":69},"2028-06-30",{"name":5,"class":6},1]